Reduced intensity versus truly nonmyeloablative conditioning for stem-cell transplant recipients

被引：9

作者：

Slavin, S ^{[1
]}

机构：

[1] Hadassah Univ Hosp, Dept Bone Marrow Transplantat & Canc Immunotherap, Cell Therapy & Transplantat Res Ctr, Jerusalem, Israel

来源：

TRANSPLANTATION | 2004年 / 78卷 / 07期

关键词：

D O I：

10.1097/01.TP.0000129810.77790.EF

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：964 / 965

页数：2

共 6 条

[1] Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy [J].

Giralt, S ;

Estey, E ;

Albitar, M ;

vanBesien, K ;

Rondon, G ;

Anderlini, P ;

OBrien, S ;

Khouri, I ;

Gajewski, J ;

Mehra, R ;

Claxton, D ;

Andersson, B ;

Beran, M ;

Przepiorka, D ;

Koller, C ;

Kornblau, S ;

Korbling, M ;

Keating, M ;

Kantarjian, H ;

Champlin, R .

BLOOD, 1997, 89 (12) :4531-4536

[2] A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation [J].

Le Blanc, K ;

Remberger, M ;

Uzunel, M ;

Mansson, J ;

Barkholt, L ;

Ringdén, O .

TRANSPLANTATION, 2004, 78 (07) :1014-1020

[3] Nonmyeloablative conditioning to induce bilateral tolerance after allogeneic bone marrow transplantation in mice [J].

Prigozhina, TB ;

Gurevitch, O ;

Slavin, S .

EXPERIMENTAL HEMATOLOGY, 1999, 27 (10) :1503-1510

[4] Prevention of graft versus host disease by inactivation of host antigen-presenting cells [J].

Shlomchik, WD ;

Couzens, MS ;

Tang, CB ;

McNiff, J ;

Robert, ME ;

Liu, JL ;

Shlomchik, MJ ;

Emerson, SG .

SCIENCE, 1999, 285 (5426) :412-415

[5] Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases [J].

Slavin, S ;

Nagler, A ;

Naparstek, E ;

Kapelushnik, Y ;

Aker, M ;

Cividalli, G ;

Varadi, G ;

Kirschbaum, M ;

Ackerstein, A ;

Samuel, S ;

Amar, A ;

Brautbar, C ;

Ben-Tal, O ;

Eldor, A ;

Or, R .

BLOOD, 1998, 91 (03) :756-763

[6] Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation [J].

Slavin, S ;

Naparstek, E ;

Nagler, A ;

Ackerstein, A ;

Samuel, S ;

Kapelushnik, J ;

Brautbar, C ;

Or, R .

BLOOD, 1996, 87 (06) :2195-2204

← 1 →